Acumen Pharmaceuticals (ABOS) Assets (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Assets of $133.6 million for Q1 2026, up 8.79% sequentially from $122.8 million in Q4 2025, and down 34.65% YoY from $204.5 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Assets (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Assets for 7 years, with the latest figure at $133.6 million in Q1 2026.
- Quarterly Assets fell 34.65% year-over-year to $133.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.6 million (down 34.65% YoY) and the FY2025 annual result came in at $122.8 million, down 48.6% from the prior year.
- Assets improved to $133.6 million in Q1 2026 per ABOS's latest filing, from $122.8 million in the prior quarter.
- Over five years, Assets peaked at $310.1 million in Q4 2023 and troughed at $122.8 million in Q4 2025.
- A 5-year average of $215.5 million and a median of $204.5 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets surged 190.2% in 2022, then sank 48.6% in 2025.
- Over 5 years, Assets stood at $196.6 million in 2022, then surged by 57.75% to $310.1 million in 2023, then retreated by 22.94% to $239.0 million in 2024, then slumped by 48.6% to $122.8 million in 2025, then advanced by 8.79% to $133.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $133.6 million, $122.8 million, and $142.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | Acumen Pharmaceuticals | 228.35 Mn | 228.35 Mn | - | 116.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.01 Mn |
| Mar 31, 2026 | 133.63 Mn |
| Dec 31, 2025 | 122.83 Mn |
| Sep 30, 2025 | 142.22 Mn |
| Jun 30, 2025 | 171.90 Mn |
| Mar 31, 2025 | 204.48 Mn |
| Dec 31, 2024 | 238.99 Mn |
| Sep 30, 2024 | 266.98 Mn |
| Jun 30, 2024 | 288.91 Mn |
| Mar 31, 2024 | 300.97 Mn |
| Dec 31, 2023 | 310.13 Mn |
| Sep 30, 2023 | 286.37 Mn |
| Jun 30, 2023 | 177.41 Mn |
| Mar 31, 2023 | 187.86 Mn |
| Dec 31, 2022 | 196.59 Mn |
| Sep 30, 2022 | 203.26 Mn |
| Jun 30, 2022 | 211.68 Mn |
| Mar 31, 2022 | 220.09 Mn |
| Dec 31, 2021 | 230.33 Mn |
| Sep 30, 2021 | 234.85 Mn |